Reduction of disease causative T-cells in experimental autoimmune disease models by a new antirheumatic drug, TAK-603

Immunopharmacology

Volumn 37, Issue 2-3, 1997, Pages 167-174

  Ohta, Yoshikazu ^a   Fukuda, Shigeru ^a   Makino, Haruhiko ^a  

^a Pharmaceutics Research Laboratory   (Japan)

Author keywords

Adjuvant arthritis transfer; Disease causative T cell; Experimental allergic encephalomyelitis; Limiting dilution assay; TAK 603

Indexed keywords

4 (3,4 DIMETHOXYPHENYL) 6,7 DIMETHOXY 2 (1,2,4 TRIAZOL 1 YLMETHYL) 3 QUINOLINECARBOXYLIC ACID ETHYL ESTER; 4 (3,4 DIMETHOXYPHENYL) 6,7 DIMETHOXY 2 (1,2,4 TRIAZOL 1 YLMETHYL)QUINOLINE 3 CARBOXYLIC ACID ETHYL ESTER; 4 (3,4 DIMETHOXYPHENYL) 6,7 DIMETHOXY 2 (1,2,4 TRIAZOLYLMETHYL) QUINOLINE 3 CARBOXYLIC ACID ETHYL ESTER; ANTIRHEUMATIC AGENT; QUINOLINE DERIVATIVE; UNCLASSIFIED DRUG;

ADJUVANT ARTHRITIS; ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; DRUG EFFECT; DRUG SCREENING; EXPERIMENTAL MODEL; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RHEUMATOID ARTHRITIS; T LYMPHOCYTE;

ANIMALS; ANTIRHEUMATIC AGENTS; ARTHRITIS, EXPERIMENTAL; AUTOIMMUNE DISEASES; CD4-CD8 RATIO; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; LYMPHOCYTE SUBSETS; MALE; QUINOLINES; RATS; RATS, INBRED LEW; SPLEEN; T-LYMPHOCYTES; TRIAZOLES;

EID: 0030781338     PISSN: 01623109     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0162-3109(97)00044-1     Document Type: Article

References (30)

1. Anderton S.M., van der Zee R., Noordzij A., van Eden W. Differential mycobacterial 65-kDa heat shock protein T-cell epitope recognition after adjuvant arthritis-inducing or protective immunization protocols. J. Immunol. 152:1994;3656-3664.
2. Baba A., Kawamura N., Makino H., Ohta Y., Taketomi S., Sohda T. Studies on disease modifying anti-rheumatic drugs (DMARDs): Synthesis of novel quinoline derivatives and their anti-inflammatory effect. J. Med. Chem. 39:1996;5176-5182.
3. Cash J.M., Klippel J.H. Second-line drug therapy for rheumatoid arthritis. N. Eng. J. Med. 330:1994;1368-1375.
4. DeJoy S.Q., Ferguson-Chanowitz K., Oronsky A.L., Zabriskie J.B., Kerwar S.S. Studies on the homing of mycobacterium-sensitized T-lymphocytes to the synovium during passive adjuvant arthritis. Cell Immunol. 130:1990;195-203.
5. Desai S., Barton R. Pharmacological comparison of active and passive experimental allergic encephalomyelitis in the rat. Agents Actions. 27:1989;351-355.
6. Duke O., Panayi G.S., Janossy G., Poulter L.W. An immuno-histological analysis of lymphocyte subpopulations and their microenvironment in the synovial membranes of patients with rheumatoid arthritis using monoclonal antibodies. Clin. Exp. Immunol. 49:1982;22-30.
7. Holoshitz J., Naparstek Y., Ben-Nun A., Cohen I.R. Lines of T-lymphocytes induce or vaccinate against autoimmune arthritis. Science. 219:1983;56-58.
8. Holoshitz J., Matitiau A., Cohen I.R. Arthritis induced in rats by cloned T-lymphocytes responsive to mycobacteria but not to collagen type II. J. Clin. Invest. 73:1984;211-215.
9. Horneff G., Burmester G.R., Emmrich F., Kalden J.R. Treatment of rheumatoid arthritis with an anti-CD4 monoclonal antibody. Arthritis Rheum. 34:1991;129-140.
10. Iigo Y., Takashi T., Tamatani T., Miyasaka M., Higashida T., Yagita H., Okumura K., Tsukada W. ICAM-1-dependent pathway is critically involved in the pathogenesis of adjuvant arthritis in rats. J. Immunol. 147:1991;4167-4171.
11. Lider O., Karin N., Shinitzky M., Cohen I.R. Therapeutic vaccination against adjuvant arthritis using autoimmune T-cells treated with hydrostatic pressure. Proc. Natl. Acad. Sci. USA. 84:1987;4577-4580.
12. Martin R., McFarland H.F., McFarlin D.E. Immunological aspects of demyelinating diseases. Annu. Rev. Immunol. 10:1992;153-187.
13. Matsumoto Y., kawai K., Tomita Y., Fujiwara M. Limiting-dilution analysis of the frequency of myelin basic protein-reactive T-cells in Lewis, PVG/c and BN rats. Implication for susceptibility to autoimmune encephalomyelitis. Immunology. 69:1990;215-221.
14. McCulloch J., Lydyard P.M., Rook G.A.W. Rheumatoid arthritis: How well do the theories fit the evidence? Clin. Exp. Immunol. 92:1993;1-6.
15. Mor F., Cohen I.R. T-cells in the lesion of experimental autoimmune encephalomyelitis: Enrichment for reactivities to myelin basic protein and to heat shock proteins. J. Clin. Invest. 90:1992;2447-2455.
16. Mor F., Cohen I.R. Shifts in the epitopes of myelin basic protein recognized by Lewis rat T-cells before, during and after the induction of experimental autoimmune encephalomyelitis. J. Clin. Invest. 92:1993;2199-2206.
17. Ohta Y., Nakagawa Y., Saijo T. Type of lymphocytes affected by the islet-activating protein (IAP). Immunopharmacology. 19:1990;197-205.
18. Ohta Y., Makino H., Fukuda S., Baba A., Nagai H., Tsukuda R., Sohda T., Shimamoto N. TAK-603, a new anti-rheumatic drug, suppresses autoimmune reactions and prevents articular destruction. Arthritis Rheum. 38:1995;S373.
19. Ohta Y., Fukuda S., Baba A., Nagai H., Tsukuda R., Sohda T., Makino H. Immunomodulating and articular protecting activities of a new anti-rheumatic drug, TAK-603. Immunopharmacology. 34:1996;17-26.
20. Ota K., Matsui M., Milford E.L., Mackin G.A., Weiner H.L., Hafler D.A. T-cell recognition of an immunodominant myelin basic protein epitope in multiple screlosis. Nature. 346:1990;183-187.
21. Panayi G.S., Lanchbury J.S., Kingsley G.H. The importance of the T-cell in initiating and maintaining the chronic synovitis of rheumatoid arthritis. Arthritis Rheum. 35:1992;729-735.
22. Pearson C.M. Development of arthritis, periarthritis and periostitis in rats given adjuvants. Proc. Soc. Exp. Biol. Med. 91:1956;95-101.
23. Sharrock C.E.M., Kaminski E., Man S. Limiting dilution analysis of human T-cells: A useful clinical tool. Immunol. Today. 11:1990;281-286.
24. Sokoloff, L., Hough, A.J., Jr., 1985. Pathology of rheumatoid arthritis and allied disorders. In: McCarthy, D.J. (Ed.), Arthritis and Allied Conditions, 10th ed. Lea and Febiger, Philadelphia, pp. 571-592.
25. Van Eden W., Holoshitz J. J., Nevo Z., Frenkel A., Klajman A., Cohen I.R. Arthritis induced by a T-lymphocyte clone that responds to mycobacterium tuberculosis and to cartilage proteoglycans. Proc. Natl. Acad. Sci. USA. 82:1985;5117-5120.
26. Van Eden W., Thole J.E.R., van der Zee R., Noordzij A., van Embden J.D.A., Hensen E.J., Cohen I.R. Cloning of the mycobacterial epitope recognized by T-lymphocytes in adjuvant arthritis. Nature. 331:1988;171-173.
27. Weisman S.M., Nemzek R.D., Anderson C.M., Coffey J.W. Oral retinoid treatment alters the development of arthritis induced by the transfer of spleen cells from rats with adjuvant arthritis (AA). Arthritis Rheum. 30:1987;s66.
28. Yang X.D., Gasser J., Feige U. Prevention of adjuvant arthritis in rats by a nonapeptide from the 65-kD mycobacterial heat-shock protein. Clin. Exp. Immunol. 81:1990;189-194.
29. Young C.L., Adamson T.C., Vaughan J.H., Fox R.I. Immunohistologic characterization of synovial membrane lymphocytes in rheumatoid arthritis. Arthritis Rheum. 27:1984;32-39.
30. Young R.A., Elliott T.J. Stress proteins, infection and immune surveillance. Cell. 59:1989;5-8.